102 related articles for article (PubMed ID: 14553942)
1. Changes in apoptosis-related pathways in acute myelocytic leukemia.
Casas S; Ollila J; Aventín A; Vihinen M; Sierra J; Knuutila S
Cancer Genet Cytogenet; 2003 Oct; 146(2):89-101. PubMed ID: 14553942
[TBL] [Abstract][Full Text] [Related]
2. Disruption of MAPK1 expression in the ERK signalling pathway and the RUNX1‑RUNX1T1 fusion gene attenuate the differentiation and proliferation and induces the growth arrest in t(8;21) leukaemia cells.
Bashanfer SAA; Saleem M; Heidenreich O; Moses EJ; Yusoff NM
Oncol Rep; 2019 Mar; 41(3):2027-2040. PubMed ID: 30569130
[TBL] [Abstract][Full Text] [Related]
3. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
[TBL] [Abstract][Full Text] [Related]
4. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
[TBL] [Abstract][Full Text] [Related]
5. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
6. CITED2 affects leukemic cell survival by interfering with p53 activation.
Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
[TBL] [Abstract][Full Text] [Related]
7. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
8. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
[TBL] [Abstract][Full Text] [Related]
9. Functional genomics in sarcoidosis--reduced or increased apoptosis?
Rutherford RM; Kehren J; Staedtler F; Chibout SD; Egan JJ; Tamm M; Gilmartin JJ; Brutsche MH
Swiss Med Wkly; 2001 Aug; 131(31-32):459-70. PubMed ID: 11641969
[TBL] [Abstract][Full Text] [Related]
10. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.
Sun X; Jia Y; Wei Y; Liu S; Yue B
Oncol Rep; 2014 Aug; 32(2):739-47. PubMed ID: 24912530
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations during p53-dependent apoptosis induced by γ-irradiation of Molt-4 leukemia cells.
Hage-Sleiman R; Bahmad H; Kobeissy H; Dakdouk Z; Kobeissy F; Dbaibo G
PLoS One; 2017; 12(12):e0190221. PubMed ID: 29272311
[TBL] [Abstract][Full Text] [Related]
13. MDM4 overexpressed in acute myeloid leukemia patients with complex karyotype and wild-type TP53.
Li L; Tan Y; Chen X; Xu Z; Yang S; Ren F; Guo H; Wang X; Chen Y; Li G; Wang H
PLoS One; 2014; 9(11):e113088. PubMed ID: 25405759
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia.
Zhang J; Huang FF; Wu DS; Li WJ; Zhan HE; Peng MY; Fang P; Cao PF; Zhang MM; Zeng H; Chen FP
Cancer Lett; 2015 Feb; 357(1):297-306. PubMed ID: 25448401
[TBL] [Abstract][Full Text] [Related]
16. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
[TBL] [Abstract][Full Text] [Related]
17. Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
Wergeland L; Sjøholt G; Haaland I; Hovland R; Bruserud Ø; Gjertsen BT
Mol Cancer; 2007 May; 6():33. PubMed ID: 17498302
[TBL] [Abstract][Full Text] [Related]
18. Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line.
Mohammadi S; Seyedhosseini FS; Behnampour N; Yazdani Y
J Recept Signal Transduct Res; 2017 Oct; 37(5):506-514. PubMed ID: 28812970
[TBL] [Abstract][Full Text] [Related]
19. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
[TBL] [Abstract][Full Text] [Related]
20. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
